Img Alt - Mobile header
Back
General Topics

2024 a:care Congress: Major milestones in medication adherence

The 2024 a:care Congress on Medication Adherence and Behavioral Science was a landmark event, setting new standards for global collaboration and innovation in healthcare. Hosted by Abbott, the congress brought together healthcare professionals, researchers, policymakers, and patient advocates to tackle one of the most critical challenges in healthcare: improving medication adherence through behavioral science.

This year’s event was a resounding success, with 75,000 registrations and almost 20,000 live attendees from around the world. Attendees spent an impressive 1 hour and 40 minutes on average actively engaging with the content, reflecting the depth of interest and the quality of discussions. The congress also achieved an extraordinary Net Promoter Score (NPS) of +66, highlighting the value participants found in this unique forum.

A Global Platform for Advancing Medication Adherence

The a:care Congress 2024 brought together experts and innovators to explore groundbreaking solutions for medication adherence. By focusing on the intersection of behavioral science, healthcare, and technology, the event offered a fresh perspective on how to address challenges in patient adherence and achieve better health outcomes.

Key highlights included:

  • World-Class Speakers: Renowned experts from behavioral science, psychology, cardiology, health economics, and healthcare policy shared their insights in engaging keynotes and interactive sessions.
  • Breakthrough Research: Attendees gained access to cutting-edge research and real-world case studies showcasing successful strategies to improve medication adherence.
  • Global Collaboration: Participants from all over the world connected, fostering a truly international exchange of ideas and best practices.

Featured Sessions

The congress featured a dynamic agenda with sessions tailored to a variety of healthcare disciplines. Some standout sessions included:

  • “The silent epidemic: Unmasking the global impact of non-adherence” – A deep dive into the size and impact of non-adherence, pointing out its critical importance in the post-COVID-19 era, marked by mistrust and misinformation, and calls for a collective effort to overcome these challenges.
  • “Non-adherence without borders: Cross continent perspectives and local realities” – Presentation of the a:care health economic study conducted in three middle-income countries: Mexico, Thailand, and China1.
  • “Don’t remind me to take my medication” – Exploration of explores the complex issue of medication non-adherence, moving beyond the common assumption that it primarily results from forgetfulness.

Celebrating Success Together

The 2024 a:care Congress wasn’t just a conference; it was a global movement. The overwhelming participation and engagement reflect the growing recognition of the importance of medication adherence in improving patient outcomes and reducing healthcare costs.

An NPS of +66 underscores the satisfaction and enthusiasm of attendees.

Watch the Recordings

If you missed the live sessions or want to revisit the valuable insights shared during the congress, we have you covered. All sessions are now available on-demand for healthcare professionals:

https://acarepro.abbott.com/acare-congress-2024-sessions/

Don’t miss this opportunity to learn from the brightest minds in medication adherence and behavioral science. Whether you’re a healthcare provider, researcher, or policymaker, these recordings will equip you with the knowledge and tools to make a real impact.

Stay tuned for updates on future events and initiatives from the a:care platform. Together, we can transform adherence and build healthier communities worldwide.

Thank you to everyone who participated in making the 2024 a:care Congress an unparalleled success. Let’s continue the conversation and drive meaningful change in healthcare.

References

  1. Cho JY, Wilson FA, Chaikledkaew U, Chen Y, Phrommintikul A, Diaz-Aguilera MA, Chen Z, Kim K, Chaiyakunapruk N. Projected Cost Savings With Optimal Medication Adherence in Patients With Cardiovascular Disease Requiring Lipid-Lowering Therapy: A Multinational Economic Evaluation Study. J Am Heart Assoc. 2024 Nov 19;13(22):e037792.

This article was written with the assistance of generative AI technology and reviewed for accuracy.